Ozempic Isn't the No. 1 Treatment for Weight Loss, New Study Finds
If you’ve been debating starting a weight-loss treatment like tirzepatide or semaglutide, you’re going to want to listen closely. In a new trial conducted by Eli Lilly, its tirzepatide injection for weight loss,
Zepbound leads to more weight loss than Wegovy, new study finds
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight loss is most effective at helping people lose more weight in less time. Zepbound,
Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says
In the first head-to-head test, people using Eli Lilly’s Zepbound lost just over 50 pounds while those using competitor Novo Nordisk’s Wegovy shed more than 33 pounds
How to get safe, lower-cost weight loss medication as demand soars
The ABC7 Chicago I-Team and ABC News are investigating the risks, and finding out how people are safely getting lower-cost versions of the drugs, as the demand soars.
Zepbound Tops Wegovy for Weight Loss in Eli Lilly Study
Shares of Eli Lilly climbed early Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nor
Eli Lilly's Zepbound beats Wegovy in head-to-head weight loss trial
Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy in a study.
Eli Lilly's Zepbound Tops Novo Nordisk's Wegovy in Weight-Loss Trial
Key Takeaways Patients taking Eli Lilly's Zepbound lost more weight on average than those on Novo Nordisk's Wegovy in a new clinical study.Zepbound patients lost an average 20% of their body weight compared with roughly 14% for those on Wegovy.
Zepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more pounds
Amid the war on obesity, a clear winner has emerged in a battle between two weight-loss injectables. Zepbound (tirzepatide), manufactured by Fortune 500 firm Eli Lilly & Co., bested competitor Wegovy (semaglutide),
In new trial, Zepbound bests Wegovy for weight loss
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly.
Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Study participants treated with Zepbound lost 20% of their body weight. A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight loss is most effective at helping people lose more weight in less time.
Lilly's Zepbound tops Wegovy for weight loss in head-to-head trial
Eli Lilly said on Wednesday patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy in the first large, head-to-head trial of the highly in-demand rival medicines.
New Drug Causes 20 Percent Weight Loss in Early Amgen Results
The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...
Wrexham.com1d
Rossett clinic warns of ‘cowboy’ businesses offering weight-loss injections as treatment demand surges
An esteemed clinician has called on people to seek proper medical care when exploring weight-loss injections. Sara Cheeney, ...
The Express Tribune8d
Amgen's experimental injection leads to 20% average weight loss in key trial
MariTide was administered monthly or less frequently, which could provide an edge over the popular weekly injections ...
BioSpace15h
Amylin Commands Weight Loss Attention as Industry Anticipates Novo’s Phase III CagriSema Readout
Amylin analogs present a strong alternative or complement to GLP-1 receptor agonists, potentially eliciting higher-quality ...
Amgen’s weight-loss injection cuts up to 20% in a year
Amgen Inc (NASDAQ: AMGN) says patients on its weight-loss injection in a mid-stage trial weighed up to 20% less on average ...
MM&M9d
Amgen’s MariTide achieves 20% weight loss, but Wall Street remains unimpressed
Amgen released the long-awaited results from its study of weight loss injection MariTide and the results — while ...
Opinion: AI is not a weight loss injection for too much bureaucracy
Germany is suffocating under its bureaucracy, AI is supposed to be the cure. Axel Kannenberg would rather see fewer ...
Amgen Obesity Drug More Effective Than Competitors
A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.